NCT06783855

Brief Summary

The suspension technique is reported as the puboprostatic ligaments that attach the prostate to the symphysis pubis. After the ligating the complex, including both the dorsal vein complex and the puboprostatic ligaments, this complex was sharply divided anteriorly from the prostate with a safe distance (1-2 mm), and the urethra is defined and divided. After removing the prostate, the ileal pouch is reconstructed by completely everting the mucosa and sutured outward with a running 4-0 absorbable suture around the edge. The neck of the neobladder was narrowed to ≈1 cm, for convenient passage of a 20 F catheter. Anastomotic sutures of 3-0 absorbable polyglactin were placed at the 1, 3, 5, 6, 7, 9, 11 and 12 o'clock positions

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Jan 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2025Jan 2027

Study Start

First participant enrolled

January 1, 2025

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

January 14, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 20, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Expected
Last Updated

January 22, 2025

Status Verified

January 1, 2025

Enrollment Period

1 year

First QC Date

January 14, 2025

Last Update Submit

January 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The continence rates at 1, 3, 6 and 12 months after the procedure will be evaluated

    Urinary continence after urethroileal suspension technique

    at 1, 3, 6 and 12 months after the procedure will be evaluated

Study Arms (2)

: group (A) 30 patients will be treated with suspension uretheroileal technique

ACTIVE COMPARATOR
Procedure: suspension uretheroileal technique

group (B) 30 patients will be treated with conventional radical cystectomy and ileal neobladder

ACTIVE COMPARATOR
Procedure: conventional radical cystectomy and ileal neobladder

Interventions

The suspension technique is reported as the puboprostatic ligaments that attach the prostate to the symphysis pubis. After the ligating the complex, including both the dorsal vein complex and the puboprostatic ligaments, this complex was sharply divided anteriorly from the prostate with a safe distance (1-2 mm), and the urethra is defined and divided. After removing the prostate, the ileal pouch is reconstructed by completely everting the mucosa and sutured outward with a running 4-0 absorbable suture around the edge. The neck of the neobladder was narrowed to ≈1 cm, for convenient passage of a 20 F catheter. Anastomotic sutures of 3-0 absorbable polyglactin were placed at the 1, 3, 5, 6, 7, 9, 11 and 12 o'clock positions through the full thickness of the urethra

: group (A) 30 patients will be treated with suspension uretheroileal technique

After removing the prostate, the ileal pouch is reconstructed by completely everting the mucosa and sutured outward with a running 4-0 absorbable suture around the edge. The neck of the neobladder was narrowed to ≈1 cm, for convenient passage of a 20 F catheter. Anastomotic sutures of 3-0 absorbable polyglactin were placed at the 1, 3, 5, 6, 7, 9, 11 and 12 o'clock positions through the full thickness of the urethra, including the mucosa and muscularis of the neobladder neck, ensuring mucosa-to-mucosa anastomosis

group (B) 30 patients will be treated with conventional radical cystectomy and ileal neobladder

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient age \>18 years.
  • Muscle-invasive bladder carcinoma (MIBC).
  • Non-muscle-invasive bladder carcinoma (NMIBC) fulfilling the following criteria:
  • \- (recurrent disease that is unresponsive to other treatments
  • \- high-grade tumors (T1, carcinoma in situ) refractory to intravesical therapy
  • Multifocal or recurrent high-grade tumors despite intravesical therapy and the tumor progression from NMIBC to MIBC).

You may not qualify if:

  • NMIBC or benign disease.
  • Severe hepatic renal dysfunction.
  • Urethral involvement with bladder carcinoma.
  • Poor overall health status.
  • Severe renal dysfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University Hospital

Sohag, Egypt

RECRUITING

Central Study Contacts

abdelrahman m abdellah, assistant lecturer

CONTACT

ahmed m mohamed, lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study will be conducted on 60 eligible patients The patients will be allocated into 2 groups: group (A) 30 patients will be treated with suspension uretheroileal technique and group (B) 30 patients will be treated without suspension technique act as control.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer urology department sohag university hospital

Study Record Dates

First Submitted

January 14, 2025

First Posted

January 20, 2025

Study Start

January 1, 2025

Primary Completion

January 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

January 22, 2025

Record last verified: 2025-01

Locations